News

The company has partnered with Andrus for the distribution of Binosto in Russia, Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, Ukraine and Uzbekistan. Through another partnership,

The collaboration target and lead inhibitors were discovered through Array’s Kinase-Directed Phenotypic Screening Platform, which relies on the company’s deep experience in kinase inhibitor chemistry and phenotypic screening

Natesto, formerly CompleoTRT, is self-administered via a nasal applicator thereby reducing the risk of secondary exposure to testosterone of women or children. Clinical Research of South Florida (CRSA)

The company also received a second patent for ZORVOLEX (diclofenac) capsules covering its manufacturing method. ZORVOLEX and TIVORBEX were approved in October 2013 and February 2014, respectively, by

Euprotec is a recognised leader in anti-infective drug discovery services. With a comprehensive portfolio of assays and disease models, underpinned by internationally recognised expertise, the company supports each

These studies are the important first step in determining the safety and tolerability of new drugs. They test how drugs are absorbed into the body, and the amount

Fibrocell’s clinical program for RDEB will utilize PCT’s manufacturing expertise and resources to implement the production process for transfer and clinical manufacturing of genetically-modified cell therapies. The manufacturing

The settlement enables Boehringer Ingelheim to focus solely on its mission of improving patients’ lives and allows the company to avoid the distraction and uncertainty of lengthy litigation.

The NDA was based on positive efficacy results from a Phase III clinical trial, in addition to a series of other clinical trials assessing pharmacokinetics, safety and abuse